- Federal agenciesProvides symbolic federal recognition that can increase public and medical community awareness of NKH.
- Potential benefitMay encourage increased participation in NKH patient registries and data sharing.
- Potential benefitCould lead to more diagnoses by prompting clinicians to test for NKH.
Expressing support for the designation of May 2, 2025, as "NKH Awareness Day".
Referred to the House Committee on Energy and Commerce.
This resolution is a non-binding statement from the House supporting the designation of May 2, 2025 as NKH Awareness Day and encouraging awareness and education about nonketotic hyperglycinemia. It does not create law, authorize spending, or direct any federal agency to take action. Its practical effect is symbolic: it signals the House's support and may encourage public, medical, and private groups to increase awareness and research efforts.
This House resolution expresses support for designating May 2, 2025, as “NKH Awareness Day,” describes nonketotic hyperglycinemia (NKH) as a rare genetic metabolic disorder, notes prevalence and diagnostic challenges, and recognizes the importance of raising awareness and improving education about NKH.
This is a simple House resolution (symbolic) that does not create law; passage in the House is likely but it will not become statutory law.
Relative to its intended legislative type, this bill functions as a concise commemorative resolution: it clearly defines NKH and designates May 2, 2025 as 'NKH Awareness Day' while providing minimal operational, fiscal, or oversight detail, which is proportionate to its symbolic purpose.
Liberal emphasizes need for research funding and equity
Who stands to gain, and who may push back.
These are examples from the analysis, not a ranked list of the most-affected groups.
- Potential burdenResolution is symbolic and does not appropriate funding or create programs.
- Potential burdenWill not directly change regulatory requirements or expand clinical services.
- Potential burdenInconsistent or uncertain epidemiological figures could confuse policymakers and the public.
Why the argument around this bill splits.
Liberal emphasizes need for research funding and equity
Likely views the resolution positively as a recognition of a rare, under-resourced disease and a step toward equity in medical attention.
Sees potential to mobilize research interest, patient registries, and clinical diagnosis improvements, though notes the text contains no funding commitments.
Sees the resolution as a low-cost, noncontroversial bipartisan gesture that can improve awareness among clinicians and the public.
Appreciates symbolic support but wants concrete outcomes or accountability to ensure real benefits.
Likely tolerant or mildly supportive because the resolution is symbolic and nonbinding, and it aids families.
May be wary of signaling future federal mandates, new spending, or expanded bureaucracy stemming from awareness efforts.
The path through Congress.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
This is a simple House resolution (symbolic) that does not create law; passage in the House is likely but it will not become statutory law.
- Whether the House schedules the measure for floor consideration
- Number and influence of cosponsors
Recent votes on the bill.
No vote history yet
The bill has not accumulated any surfaced votes yet.
Go deeper than the headline read.
Liberal emphasizes need for research funding and equity
This is a simple House resolution (symbolic) that does not create law; passage in the House is likely but it will not become statutory law.
Relative to its intended legislative type, this bill functions as a concise commemorative resolution: it clearly defines NKH and designates May 2, 2025 as 'NKH Awareness Day' while providing minimal operational, fiscal,…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.